Ignite Creation Date:
2024-05-05 @ 11:40 AM
Last Modification Date:
2024-10-26 @ 9:11 AM
Study NCT ID:
NCT00103506
Status:
COMPLETED
Last Update Posted:
2015-10-19
First Post:
2005-02-09
Brief Title:
Study of DOXILCAELYX Pegylated Liposomal Doxorubicin and VELCADE Bortezomib or VELCADE Monotherapy for the Treatment of Relapsed Multiple Myeloma
Sponsor:
Janssen Research Development LLC
Organization:
Janssen Research Development LLC
Organization Data
Organization:
Janssen Research Development LLC
Class:
INDUSTRY
Study ID:
CR004117
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Janssen Research Development LLC
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None